About Cyanotech
Cyanotech (NASDAQ:CYAN) specializes in the production and sale of microalgae-based health and nutritional products, focusing on Spirulina and Astaxanthin which are used in dietary supplements as well as food and beverage applications. These microalgae are cultivated in its Kona, Hawaii facility, capitalizing on the unique climatic conditions to ensure high-quality production. Cyanotech's primary objective is to improve global health and nutrition by harnessing the potential of microalgae, aiming to expand its reach and product offerings through continuous research and development, sustainable practices, and innovative technology. The company is committed to environmental stewardship and aims to deliver value not only to its customers but also to its shareholders by maintaining high standards in its operational efficiency and product quality.
Snapshot
Operations
Produtos e/ou serviços de Cyanotech
- Astaxanthin production for dietary supplements, focusing on health benefits like improved skin health, and increased energy levels.
- Spirulina cultivation for nutritional supplements, targeting immune support and nutritional balance.
- Research and development in microalgae-based products, aiming at exploring new beneficial compounds.
- Wholesale distribution of bulk raw materials, including microalgae, for various markets.
- Private labeling services offering customized packaging and branding for clients' products.
- E-commerce platform providing direct-to-consumer sales of health supplements.
equipe executiva do Cyanotech
- Mr. Matthew Keith CusterPresident, CEO & Director
- Dr. Gerald R. Cysewski Ph.D.Co-Founder, CEO Emeritus & Chief Scientific Officer
- Ms. Jennifer MiyashiroCFO, VP of Finance & Administration and Treasurer
- Mr. Glenn D. JensenVice President of Operations
- Ms. Jennifer K. BrandVice President of Sales
- Ms. Amy Beth NordinVP of HR & Corporate Secretary
- Ms. Collette N. KakukChief Strategic & Commercial Officer